On 4 April 2019, Medacta Group SA, a pure play orthopaedics company, opened the IPO-season 2019 at SIX Swiss Exchange with the first day of trading of its shares. The shares of Medacta were priced at CHF 96.00 per share and on 3 May 2019, Medacta announced that the Joint Global Coordinators (Credit Suisse and Morgan Stanley) have partially exercised the over-allotment option in the amount of 438,472 existing shares at the offer price.

Including the shares placed in connection with the over-allotment option, a total of 6,138,472 existing shares have been sold in the IPO, increasing the free float to 30.7%, with the Siccardi family holding 69.3% of Medacta’s share capital. The total placement volume amounts to CHF 589 million.